643 related articles for article (PubMed ID: 33062602)
1. Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment.
Malekghasemi S; Majidi J; Baghbanzadeh A; Abdolalizadeh J; Baradaran B; Aghebati-Maleki L
Adv Pharm Bull; 2020 Sep; 10(4):556-565. PubMed ID: 33062602
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumor-associated macrophages in the tumor microenvironment.
Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
[TBL] [Abstract][Full Text] [Related]
3. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
4. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
[TBL] [Abstract][Full Text] [Related]
5. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J; Liang Y; Wang L
Front Immunol; 2022; 13():888713. PubMed ID: 35844605
[TBL] [Abstract][Full Text] [Related]
6. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
[TBL] [Abstract][Full Text] [Related]
7. Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment.
Olsson A; Nakhlé J; Sundstedt A; Plas P; Bauchet AL; Pierron V; Bruetschy L; Deronic A; Törngren M; Liberg D; Schmidlin F; Leanderson T
J Immunother Cancer; 2015; 3():53. PubMed ID: 26673090
[TBL] [Abstract][Full Text] [Related]
8. Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?
Tong N; He Z; Ma Y; Wang Z; Huang Z; Cao H; Xu L; Zou Y; Wang W; Yi C; Yin Z; Wang Q
Front Cell Dev Biol; 2021; 9():706286. PubMed ID: 34368156
[TBL] [Abstract][Full Text] [Related]
9. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials.
Zhang W; Wang M; Ji C; Liu X; Gu B; Dong T
Biomed Pharmacother; 2024 Jun; 177():116930. PubMed ID: 38878638
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Obesity, Adipose Tissue, and Tumor Microenvironment on Macrophage Polarization and Metastasis.
Habanjar O; Diab-Assaf M; Caldefie-Chezet F; Delort L
Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205204
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages: from basic research to clinical application.
Yang L; Zhang Y
J Hematol Oncol; 2017 Feb; 10(1):58. PubMed ID: 28241846
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.
Jarboe T; Tuli NY; Chakraborty S; Maniyar RR; DeSouza N; Xiu-Min Li ; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():1-31. PubMed ID: 34888842
[TBL] [Abstract][Full Text] [Related]
14. The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets.
Ren J; Xu B; Ren J; Liu Z; Cai L; Zhang X; Wang W; Li S; Jin L; Ding L
Brain Sci; 2023 Aug; 13(9):. PubMed ID: 37759870
[TBL] [Abstract][Full Text] [Related]
15. [Influencing Factors and Significance of Tumor-associated Macrophage Polarization
in Tumor Microenvironment].
Ge W; Wu W
Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):228-237. PubMed ID: 37035885
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages as a potential therapeutic target in thyroid cancers.
Zhu L; Li XJ; Gangadaran P; Jing X; Ahn BC
Cancer Immunol Immunother; 2023 Dec; 72(12):3895-3917. PubMed ID: 37796300
[TBL] [Abstract][Full Text] [Related]
18. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
[TBL] [Abstract][Full Text] [Related]
19. The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.
Ge Z; Ding S
Front Oncol; 2020; 10():590941. PubMed ID: 33224886
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.
Szulc-Kielbik I; Kielbik M
Exp Suppl; 2022; 113():107-140. PubMed ID: 35165862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
